1. Biomarkers in 5q-associated spinal muscular atrophy—a narrative review

   • H. S. Lapp
   • M. Freigang
   • René Günther

   Review Open access 08 June 2023 Pages: 4157 - 4178

   

2. The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis

   • Erica Grange
   • Claudio Solaro
   • Davide Marengo

   Review Open access 09 June 2023 Pages: 4179 - 4191

   

3. Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis

   • Huo Liang
   • Xue Wang
   • Zhijian Liang

   Review 14 June 2023 Pages: 4192 - 4200

   

4. Comorbidity of epilepsy and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

   • Shun Wang
   • Baozhen Yao
   • Zhongchun Liu

   Review 16 June 2023 Pages: 4201 - 4213

   

5. Impacts of exposure to ambient temperature and altitude on the burden of stroke

   • Wen-Jun Tu
   • Yicheng Xu
   • Jizong Zhao

   Original Communication 11 May 2023 Pages: 4214 - 4218

   

6. Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients

   • Chiara Benzoni
   • Marco Moscatelli
   • Ettore Salsano

   Original Communication 12 May 2023 Pages: 4219 - 4234

   

7. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers

   • Peter Bede
   • Dorothée Lulé
   • Jan Kassubek

   Original Communication Open access 13 May 2023 Pages: 4235 - 4247

   

8. Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study

   • Linliu Peng
   • Linlin Wan
   • Hong Jiang

   Original Communication 15 May 2023 Pages: 4248 - 4261

   

9. Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP)

   • Renana Mertin
   • Cid Diesta
   • Andreas Sprenger

   Original Communication Open access 16 May 2023 Pages: 4262 - 4275

   

10. The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD

    • Camila Maria de Oliveira
    • Vanessa Bielefeldt Leotti
    • Laura Bannach Jardim

    Original Communication 16 May 2023 Pages: 4276 - 4287

    

11. Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study

    • Bingyou Liu
    • Jianian Hu
    • Chongbo Zhao

    Original Communication 17 May 2023 Pages: 4288 - 4295

    

12. Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study

    • Matteo Azzimonti
    • Paolo Preziosa
    • Massimo Filippi

    Original Communication 18 May 2023 Pages: 4296 - 4308

    

13. Digital measures of freezing of gait across the spectrum of normal, non-freezers, possible freezers and definite freezers

    • Martina Mancini
    • Naoya Hasegawa
    • John G. Nutt

    Original Communication 19 May 2023 Pages: 4309 - 4317

    

14. Identifying large vessel occlusion at first glance in telemedicine

    • Nils Schröter
    • Antonia Weiller
    • Lena-Alexandra Beume

    Original Communication Open access 18 May 2023 Pages: 4318 - 4325

    

15. A cross-sectional study on the neurocognitive outcomes in vestibular impaired school-aged children: are they at higher risk for cognitive deficits?

    • Ruth Van Hecke
    • Maya Danneels
    • Leen Maes

    Original Communication 20 May 2023 Pages: 4326 - 4341

    

16. Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson’s disease: a clinical-instrumental study

    • Francesco Cavallieri
    • Isabella Campanini
    • Franco Valzania

    Original Communication 20 May 2023 Pages: 4342 - 4353

    

17. Intravenous thrombolysis and mechanical recanalization for acute ischemic stroke in deep brain stimulation patients: a case series

    • Johannes Meyne
    • Mirjam Domschikowski
    • Steffen Paschen

    Original Communication Open access 22 May 2023 Pages: 4354 - 4359

18. The “Vestibular Eye Sign”—“VES”: a new radiological sign of vestibular neuronitis can help to determine the affected vestibule and support the diagnosis

    • Raed Farhat
    • Anan Abu Awad
    • Saqr Massoud

    Original Communication Open access 23 May 2023 Pages: 4360 - 4367

    

19. Tumefactive brain parenchymal neurosarcoidosis

    • Gabriela A. Bou
    • Sally El Sammak
    • Spencer K. Hutto

    Original Communication 23 May 2023 Pages: 4368 - 4376

    

20. Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

    • Keisuke Suzuki
    • Shiho Suzuki
    • Koichi Hirata

    Original Communication 23 May 2023 Pages: 4377 - 4384

    

21. Reduced ¹²³I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson’s disease identified using a quantitative semi-automatic method

    • Junya Ebina
    • Sunao Mizumura
    • Osamu Kano

    Original Communication 24 May 2023 Pages: 4385 - 4392

    

22. Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder

    • Don Gueu Park
    • Ju Yeong Kim
    • Jung Han Yoon

    Original Communication 26 May 2023 Pages: 4393 - 4402

    

23. A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis

    • C. Louapre
    • M. Rosenzwajg
    • D. Klatzmann

    Original Communication 28 May 2023 Pages: 4403 - 4414

    

24. Progression of initially unilateral Moyamoya angiopathy in Caucasian Europeans

    • Daniel Strunk
    • Rolf R. Diehl
    • Markus Kraemer

    Original Communication 01 June 2023 Pages: 4415 - 4422

    

25. Assessing balance in people with bilateral vestibulopathy using the Mini-Balance Evaluation Systems Test (Mini-BESTest): feasibility and comparison with healthy control data

    • Meichan Zhu
    • Lisa van Stiphout
    • Christopher McCrum

    Original Communication Open access 03 June 2023 Pages: 4423 - 4433

    

26. Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis

    • Sinja Vogt
    • Felix Kleefeld
    • Katrin Hahn

    Original Communication Open access 06 June 2023 Pages: 4434 - 4443

    

27. Association between peripheral adaptive immune markers and disease progression in Parkinson's disease

    • Yi Xiao
    • Qianqian Wei
    • Huifang Shang

    Original Communication 06 June 2023 Pages: 4444 - 4450

28. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis

    • Shane Lyons
    • Dominic Trépel
    • Sean O’Dowd

    Original Communication Open access 08 June 2023 Pages: 4451 - 4465

    

29. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups

    • Jing Zhao
    • Wenting Zeng
    • Jianping Chu

    Original Communication 08 June 2023 Pages: 4466 - 4477

    

30. Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy’s disease

    • Alessandro Miscioscia
    • Marco Puthenparampil
    • Paolo Gallo

    Original Communication Open access 08 June 2023 Pages: 4478 - 4486

    

31. Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models

    • Alessandro Gialluisi
    • Maria Ilenia De Bartolo
    • Licia Iacoviello

    Original Communication 09 June 2023 Pages: 4487 - 4497

    

32. Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy

    • Nolwenn Krief
    • René Gabriel
    • Andoni Echaniz-Laguna

    Original Communication 09 June 2023 Pages: 4498 - 4506

    

33. Pupillometry in the follow-up of patients undergoing EVT - prediction of space-occupying hemispheric infarction

    • Clara-Sophie Kossel
    • Franca Kobus
    • Julia Koehn

    Original Communication Open access 10 June 2023 Pages: 4507 - 4517

    

34. Real-world experience with VMAT2 inhibitors in Tourette syndrome

    • Karim Makhoul
    • Joseph Jankovic

    Original Communication 11 June 2023 Pages: 4518 - 4522

    

35. TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience

    • Pitcha Chompoopong
    • Mohamed Rezk
    • Divyanshu Dubey

    Short Commentary 09 June 2023 Pages: 4523 - 4528

    

36. Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation

    • Naoko Nakamura
    • Hidehiro Ishikawa
    • Hidekazu Tomimoto

    Letter to the Editors 03 May 2023 Pages: 4529 - 4532

    

37. The expanding spectrum of antibody-associated cerebellar ataxia: report of two new cases of anti-AP3B2 ataxia

    • Andreu Vilaseca
    • Le-Duy Do
    • Jérôme Honnorat

    Letter to the Editors 03 May 2023 Pages: 4533 - 4537

    

38. PLIN4-related myopathy: clinical, histological and imaging data in a large cohort of patients

    • Lorenzo Maggi
    • Sara Gibertini
    • Alessandra Ruggieri

    Letter to the Editors Open access 05 May 2023 Pages: 4538 - 4543

    

39. RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study

    • Goichi Beck
    • Yuki Yonenobu
    • Hideki Mochizuki

    Letter to the Editors 08 May 2023 Pages: 4544 - 4548

    

40. Image features of anti-SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism

    • Dingding Shen
    • Qinming Zhou
    • Sheng Chen

    Letter to the Editors 10 May 2023 Pages: 4549 - 4553

    

41. Correction to: Image features of anti‑SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism

    • Dingding Shen
    • Qinming Zhou
    • Sheng Chen

    Correction 19 July 2023 Pages: 4554 - 4554

42. Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome

    • Jennifer A. McCombe
    • Bryan T. Klassen
    • Andrew McKeon

    Letter to the Editors Open access 18 May 2023 Pages: 4555 - 4557

43. Neurological update: non-motor symptoms in atypical parkinsonian syndromes

    • Piriyankan Ananthavarathan
    • B. Patel
    • N. Malek

    Neurological Update Open access 15 June 2023 Pages: 4558 - 4578

44. Clinical trials in myasthenia gravis

    • A. Mahmood
    • J. Hawken
    • N. P. Robertson

    Journal club Open access 31 July 2023 Pages: 4579 - 4581

45. Correction to: Encephalitis in HIV‑infected adults in the antiretroviral therapy era

    • Melissa Reimer-McAtee
    • Denisse Ramirez
    • Rodrigo Hasbun

    Correction 05 June 2023 Pages: 4582 - 4582

46. Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis

    • Eugenio Mercuri
    • Andrés Nascimento Osorio
    • the STRIDE and CINRG DNHS investigators

    Correction Open access 17 July 2023 Pages: 4583 - 4583